The glaucoma specialist said doctors are intervening earlier and more aggressively to lower IOP.
The drugmaker plans to grow in ophthalmology by advancing its current pipeline and adding candidates for the posterior segment.
US lawmakers tell the agency’s chief that recent policy shifts are creating supply chain vulnerabilities.
Spark will commercialize its treatment in the US as Luxturna.
US presbyopia market now has only one available inlay, the KAMRA.
The IRS collected $1.4 billion in medical device taxes in 2013 and $1.9 billion in 2014.
Argus II surgeries in 2017 rose 79 percent over the previous year.
Surgeons use Omidria during cataract surgery for maintaining pupil size and reducing postoperative ocular pain.
The agency will require additional sterility testing.
Market Scope estimates that more than 1.7 million vitrectomies will be performed globally in 2018.
The jury was deadlocked 10-2 in favor of acquittal.
Five other companies raised funds in the past month, pushing the total to $144.4 million.
You are not currently logged in.
©2018 Market Scope
Lost your Password